These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17022786)

  • 1. The yield of expanding the therapeutic time window for tPA.
    Owe JF; Sanaker PS; Naess H; Thomassen L
    Acta Neurol Scand; 2006 Nov; 114(5):354-7. PubMed ID: 17022786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why are eligible thrombolysis candidates left untreated?
    Hills NK; Johnston SC
    Am J Prev Med; 2006 Dec; 31(6 Suppl 2):S210-6. PubMed ID: 17178305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prioritizing interventions to improve rates of thrombolysis for ischemic stroke.
    California Acute Stroke Pilot Registry (CASPR) Investigators
    Neurology; 2005 Feb; 64(4):654-9. PubMed ID: 15728287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obstacles to the use of intravenous tissue plasminogen activator for acute ischemic stroke. Is time the only barrier?
    Laloux P; Thijs V; Peeters A; Desfontaines P
    Acta Neurol Belg; 2007 Dec; 107(4):103-7. PubMed ID: 18416282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of tissue plasminogen activator for acute ischemic stroke in a rural Wisconsin hospital.
    Charipar R; Charipar E
    WMJ; 2008 Jul; 107(4):176-80. PubMed ID: 18702433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the stroke code activation source on the outcome of acute ischemic stroke patients.
    de la Ossa NP; Sánchez-Ojanguren J; Palomeras E; Millán M; Arenillas JF; Dorado L; Guerrero C; Abilleira S; Dávalos A
    Neurology; 2008 Apr; 70(15):1238-43. PubMed ID: 18322264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute stroke management in the elderly.
    Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
    Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of intravenous tissue plasminogen activator for ischemic stroke: are there sex differences?
    Allen NB; Myers D; Watanabe E; Dostal J; Sama D; Goldstein LB; Lichtman JH
    Cerebrovasc Dis; 2009; 27(3):254-8. PubMed ID: 19176959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of intravenous recombinant tissue plasminogen activator in acute ischemic stroke.
    Kahn JH; Viereck J; Kase C; Jeerakathil T; Romero R; Mehta SD; Kociol R; Babikian V
    J Emerg Med; 2005 Oct; 29(3):273-7. PubMed ID: 16183445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of intravenous tissue plasminogen activator for acute ischemic stroke.
    Katzan IL; Hammer MD; Hixson ED; Furlan AJ; Abou-Chebl A; Nadzam DM;
    Arch Neurol; 2004 Mar; 61(3):346-50. PubMed ID: 15023810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thrombolysis in stroke: inappropriate consideration of the 'window period' as the time available].
    Maestre-Moreno JF; Fernández-Pérez MD; Arnáiz-Urrutia C; Mínguez A; Navarrete-Navarro P; Martínez-Bosch J
    Rev Neurol; 2005 Mar 1-15; 40(5):274-8. PubMed ID: 15782357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use and misuse of thrombolytic therapy within the Veterans Health Administration.
    Keyhani S; Arling G; Williams LS; Ross JS; Ordin DL; Myers J; Tyndall G; Vogel B; Bravata DM
    Med Care; 2012 Jan; 50(1):66-73. PubMed ID: 22182924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the reasons for exclusion from tPA therapy after early arrival in acute stroke patients.
    García-Moncó JC; Pinedo A; Escalza I; Ferreira E; Foncea N; Gómez-Beldarrain M; Ruiz-Ojeda J; Mateo I; Mediavilla J; Basterretxea JM
    Clin Neurol Neurosurg; 2007 Jan; 109(1):50-3. PubMed ID: 16887258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing in-hospital delay to 20 minutes in stroke thrombolysis.
    Meretoja A; Strbian D; Mustanoja S; Tatlisumak T; Lindsberg PJ; Kaste M
    Neurology; 2012 Jul; 79(4):306-13. PubMed ID: 22622858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time to hospital arrival, use of thrombolytics, and in-hospital outcomes in ischemic stroke.
    Qureshi AI; Kirmani JF; Sayed MA; Safdar A; Ahmed S; Ferguson R; Hershey LA; Qazi KJ;
    Neurology; 2005 Jun; 64(12):2115-20. PubMed ID: 15985583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous thrombolysis for ischaemic stroke: short delays and high community-based treatment rates after organisational changes in a previously inexperienced centre.
    Tveiten A; Mygland A; Ljøstad U; Thomassen L
    Emerg Med J; 2009 May; 26(5):324-6. PubMed ID: 19386862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why ischemic stroke patients do not receive thrombolytic treatment: results from a general hospital.
    van den Berg JS; de Jong G
    Acta Neurol Scand; 2009 Sep; 120(3):157-60. PubMed ID: 19719807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distance from home to hospital and thrombolytic utilization for acute ischemic stroke.
    Acharya AB; Nyirenda JC; Higgs GB; Bloomfield MS; Cruz-Flores S; Connor LT; Lee JM; Leet TL
    J Stroke Cerebrovasc Dis; 2011; 20(4):295-301. PubMed ID: 20634096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telephonic guidance of systemic thrombolysis in acute ischemic stroke: safety outcome in rural hospitals.
    Vaishnav AG; Pettigrew LC; Ryan S
    Clin Neurol Neurosurg; 2008 May; 110(5):451-4. PubMed ID: 18353532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.